NEW: Many individual investors stormed the market this year to buy the dip

They're facing one of the biggest tests yet-in one of the WORST years for buying the dip since 1970s

My latest w @mccabe_caitlin

wsj.com/articles/buy-t… @JohnBCase @sentimentrader @jasongoepfert

"Even among trading platforms often associated with more conservative retail investor bases...such as Charles Schwab or TD-Ameritrade, 25% of the trades placed reflect buying of options" - @VandaTrack

Vanda estimates options trading at Schwab hit a **high** in Feb 22

Retail traders scooped up just $387 million worth of U.S.-listed stocks and ETFs on Tuesday (after NASDAQ 100 closed in bear market territory on Monday) … lowest total since late-2020 per ⁦@VandaTrack⁩

Digging deeper into the anatomy of the recent rally, we see that heavily shorted stocks have led the rebound #ShortInterest #USequities

source: @VandaTrack

Call options chatter on WSB is on the decline -@VandaTrack

Day traders as "dumb money"? Not anymore. Some 85% of hedge funds and 42% of asset managers are now tracking retail-trading message boards, according to a survey by Bloomberg Intelligence.

My latest: on.wsj.com/3GClY5f

A few interesting findings as I reported this: Retail investors have shown a strong stomach for bumpy days. Last year, the group’s eight largest buying days occurred when the S&P 500 sank 1.3% or more, according to @VandaTrack data.

🟣 Retail investors trying their best to offset the broken Powell put but the level of buying in recent days has been a fraction of what we saw earlier in the year (Jan '21) or after Omicron sell-off in late Nov '21. US equity market skating on thin ice
$SPX @VandaTrack

Retail investors not yet disturbed by recent market weakness ... when #omicron caused volatility to spike, retail net stock purchases spiked to highest on record last week
⁦@FT⁩ ⁦@Refinitiv⁩ ⁦@VandaTrack⁩

🟣 Friday's 'Omicron' sell-off saw the second biggest day of net retail buying of US stocks on record ($2.04bn). Similar to what we saw after the Delta sell-off in July where the retail crowd also looked to snap up some bargains. Positive sign for US equity bulls @VandaTrack $SPX

Pandemic/stimulus unleashed cult of equities
@VandaTrack

$BITO was heavily traded, but not really by retail investors, according to @VandaTrack

Vanda estimates retail traders bought ~$8 million worth of the shares, compared to $57 mln for the COIN IPO in March

Highly requested new feature released yesterday for VandaTrack clients, showing total turnover alongside retail investor only net purchases, for all US-listed stocks / ETFs.

Email salesvt@vanda.com for more information.
#equities

'Buy the pill, sell the vax': Retail investors are scooping up shares of antiviral pill maker Merck $MRK and selling COVID vaccine makers, says @VandaTrack

markets.businessinsider.com/news/stocks/me…

Yesterday Retail Investors recorded the 4th largest net buying day of US-listed stocks and ETFs totalling just under US$2bn.

To see the breakdown of what they bought get in touch by emailing salesvt@vanda.com.
#equities

Retail investors less aggressive buyers of U.S. equity ETFs during recent market dip relative to prior 3 dips
@vandaresearch @Bloomberg

Vanda Research estimates that yesterday was the FIRST time since February that individual investors were net sellers of AMC

@VandaTrack

No surprise here but retail investors’ equity purchases have picked up substantially post-pandemic @WSJ @VandaTrack

"Chinese tech ADRs recorded the largest retail purchases in five years, exceeding US$ 400 mln in net purchases."

Via @VandaTrack

Tons of call options trading in Moderna, Pfizer and other vaccine manufacturers this week---surpassing levels from when clinical trials were released last year @VandaTrack

$MRNA $PFE